---
title: "Zhenhua Tech: Will actively extend into strategic emerging fields such as commercial aerospace and low-altitude economy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262777253.md"
description: "On October 26th, Zhenhua Tech stated on the interactive platform that the company's power devices are currently focused on the high-tech electronics field; in the next step, the company will continue to strengthen the strategic position of its civilian business and actively extend into strategic emerging fields such as commercial aerospace, low-altitude economy, civil aviation, new energy vehicles, and rail transit"
datetime: "2025-10-26T14:01:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262777253.md)
  - [en](https://longbridge.com/en/news/262777253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262777253.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262777253.md) | [繁體中文](https://longbridge.com/zh-HK/news/262777253.md)


# Zhenhua Tech: Will actively extend into strategic emerging fields such as commercial aerospace and low-altitude economy

On October 26th, Zhenhua Tech stated on the interactive platform that the company's power devices are currently focused on the high-tech electronics field; in the next step, the company will continue to strengthen the strategic position of its civilian business and actively extend into strategic emerging fields such as commercial aerospace, low-altitude economy, civil aviation, new energy vehicles, and rail transit

### Related Stocks

- [Zhenhua Tech (000733.CN)](https://longbridge.com/en/quote/000733.CN.md)

## Related News & Research

- [MedSpa Partners Announces Strategic Executive Leadership Team Appointments to Drive Next Phase of Growth](https://longbridge.com/en/news/277657198.md)
- [13:45 ETAn InventHelp 123Invent Client Develops New Hour Logging & License Scanning System (TKI-1292)](https://longbridge.com/en/news/277238882.md)
- [08:43 ETThe Dyrt Publishes Seven Road Trip Guides That Span America](https://longbridge.com/en/news/277632014.md)
- [Vial Doses First Patient for Phase 1 Trial of Vial’s IL-13 x TSLP, a Novel Bispecific Antibody](https://longbridge.com/en/news/277585325.md)
- [Nasa for Artemis III: Added new demonstration mission in low earth orbit in mid-2027 to test one or both commercial landers from SpaceX, Blue Origin](https://longbridge.com/en/news/277687007.md)